CT Perfusion Imaging for Evaluating Neoadjuvant Chemotherapy in Bone Neoplasms

SHI Xin,WU Su-jia,JIN Ji-yang,ZUO Yan-hai
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2009.16.014
2009-01-01
Abstract:OBJECTIVE:To investigate the hemodynamic changes of primary malignant bone tumors before and after neoadjuvant chemotherapy using CT perfusion imaging(CTPI).METHODS:Thirteen patients with malignant bone tumors confirmed by pathology were enrolled in the study in which systemic chemotherapy was used to assess the tumor response.The pathological types of bone tumors were as follows:osteosarcoma in 6 cases,epithelioide sarcoma in 1 case,primitive neuroectodermal tumor(PNET)in 4 cases,synovial sarcoma in 1 case and chondrosarcoma in 1 case.All the patients underwent CTPI 1-5 days before and 1-3 weeks after chemotherapy for the perfusion parameters including blood flow(BF),blood volume(BV),time to peak(TTP)and permeability surface(PS).Perfusion parameters before and after chemotherapy were compared.Statistical analysis was performed with Wilcoxon signed-rank test.RESULTS:The following changes in median(M)pre-and post-induction chemotherapy values were noted as follows:BF 52.800 mL/(100 g·min)and 53.000 mL/(100 g·min);BV 65.300 mL/100 g and 67.600 mL/100 g;TTP 120.300 s and 114.900 s;PS 40.100 mL/(100 g·min)to 48.500 mL/(100 g·min).There was no significant difference in BF,BV and TTP between pre-and post-induction chemotherapy(P were 0.382,0.075 and 0.701 respectively).After chemotherapy,tumors showed a significant increase in PS(P=0.046).CONCLUSION:PS may be useful for assessing the changes in blood perfusion of primary malignant bone tumors after neoadjuvant chemotherapy,while BF,BV or TTP not.
What problem does this paper attempt to address?